Asset Publisher

< Back to Blue Advantage Final Medical Policies page

Final Policies: A - E

Policy # Policy Title View
BA-721 Absorbable Nasal Implant for Treatment of Nasal Valve Collapse
BA-071 Allergy Testing
BA-624 Amniotic Membrane Grafts for Ophthalmic Indications
BA-311 Anterior Eye Segment Optical Imaging
BA-353 Anti-CCP Testing for Rheumatoid Arthritis
BA-324 Aqueous Shunts and Stents for Glaucoma
BA-146 Auditory Brain Stem Implant
BA-156 Autologous Chondrocyte Implantation for Focal Articular Cartilage Lesions
BA-573 Autonomic Nervous System Testing
BA-704 Balloon Dilation of the Eustachian Tube
BA-055 Bi-Ventricular Pacemakers (Cardiac Resynchronization Therapy) for the Treatment of Heart Failure
BA-232 Biophysical Fetal Profile
BA-189 Bone Morphogenetic Protein
BA-266 Boniva® (Ibandronate Sodium) Infusion
BA-198 Cardiopulmonary Exercise Stress Test (CPET-CPX)
BA-432 Cellular Immunotherapy for Prostate Cancer
BA-085 Chelation Therapy
BA-052 Chemical Peels
BA-204 Computed Tomography Perfusion Imaging of the Brain
BA-038 Continuous Glucose Monitoring
BA-639 Corneal Collagen Cross-Linking
BA-429 Cryoablation of Tumors (Excluding Liver or Prostate Tumors)
BA-558 Diagnosis and Treatment of Sacroiliac Joint Pain
BA-252 Digital Breast Tomosynthesis
BA-368 Digital Electroencephalography (DEEG) Analysis
BA-504 Dopamine Transporter Imaging with Single Photon Emission Computed Tomography (DAT-SPECT)
BA-735 DURYSTA (bimatoprost implant)
BA-576 Endobronchial Ultrasound for Diagnosis and Staging of Lung Cancer
BA-453 Endometrial Ablation
BA-637 Endovascular Stent Grafts for Thoracic Aortic Aneurysms or Dissections
BA-224 Extracorporeal Shock Wave Lithotripsy (ESWL) for Pancreatic Stones